Kirsten L. Greene, MD, MAS, FACS, discusses the future of personalized therapy in prostate cancer.
Kirsten L. Greene, MD, MAS, FACS
Advertisement
Articles by Kirsten L. Greene, MD, MAS, FACS
Advertisement
Latest Updated Articles
Dr. Greene on the Future of Personalized Therapy in Prostate CancerNovember 18th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
3
CLL14 Final Analysis Shows Long-Term PFS Gain With Venetoclax/Obinutuzumab in Previously Untreated CLL
4
Data Support Luspatercept at Maximum-Approved Dose for Transfusion-Dependent Lower-Risk MDS
5